🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kei Namba

Okayama Rosai Hospital

ORCID: 0000-0002-0748-3979

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer”.

Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer

Scientific Reports(2022)10.1038/s41598-022-06772-w

N/A

0DataRank · unranked

19 citations

Atsushi Tanaka, Kei Namba, Jinru Shia, Julia Y. Wang, Michael H. A. Roehrl +1 more

Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer

Frontiers in Oncology(2022)10.3389/fonc.2022.802548

N/A

0DataRank · unranked

11 citations

Atsushi Tanaka, Kei Namba, Jinru Shia, Julia Y. Wang, Michael H. A. Roehrl +1 more

Proteogenomic characterization of primary colorectal cancer and metastatic progression identifies proteome-based subtypes and signatures

Cell Reports(2024)10.1016/j.celrep.2024.113810

N/A

0DataRank · unranked

26 citations

Makiko Ogawa, Yihua Zhou, Kei Namba, Ronald C. Hendrickson, Matthew M. Miele +7 more

Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer

PLoS ONE(2024)10.1371/journal.pone.0298362

N/A

0DataRank · unranked

10 citations

Atsushi Tanaka, Masaki Maekawa, Kei Namba, Yusuke Otani, Jinru Shia +3 more